clinical trial · NCT06553924
Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg
Humanis Saglık Anonim Sirketi·phase1·completed·n = 30
PAHMacitentan and Tadalafil film-coated tabletsPrOpsynvi® macitentan and tadalafil film-coated tablets
brief summary
Single dose oral bioequivalence study of Macitentan and Tadalafil film-coated tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil film-coated tablets 10 mg/40 mg in healthy adult male subjects under fasting conditions.
started
May 14, 2024
primary completion
May 31, 2024
completion
Aug 8, 2024
last updated
Aug 14, 2024
official title
Single Dose Oral Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg in Healthy Adult Male Subjects Under Fasting Conditions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol